Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Drugs in Pipeline
5
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Jun 15, 2026
25w| Drug Name | Phase |
|---|---|
Irbesartan | Phase 3 |
Dapagliflozin | Phase 3 |
Pegtibatinase | Phase 2 |
Sparsentan | Phase 2 |
RE-021 (Sparsentan) | Phase 2 |
1 upcoming, 1 past
Primary completion for Pegtibatinase trial (NCT03406611) in Homocystinuria
Source